Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Obesity-induced ED Response to Combined Effect of Tadalafil Drug in Addition to Interval and Continuous Training

NCT04623840 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT04623840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04623840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Obesity-induced ED Response to Combined Effect of Tadalafil Drug in Addition to Interval and Continuous Training
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Unknown status
Start date
October 12, 2020
Completion date
March 30, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction